References
- Acher, R., Chauvet, J., and Rouille, Y. 2002. Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport. Journal of Molecular Neuroscience, 18, 223–228.
- Aoyagi, T., Koshimizu, T.A., and Tanoue, A. 2009. Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice. Kidney International, 76, 1035–1039.
- Berukstis, A., et al., 2016. Impact of renal sympathetic denervation on cardiac sympathetic nerve activity evaluated by cardiac MIBG imaging. EuroIntervention, 11, 1070–1076.
- Bhatt, D.L., and Bakris, G.L. 2014. Renal denervation for resistant hypertension. New England Journal of Medicine, 371, 184.
- Bonjour, J.P., and Malvin, R.L. 1970. Stimulation of ADH release by the renin-angiotensin system. American Journal of Physiology, 218, 1555–1559.
- Coleman, C.G., Anrather, J., Iadecola, C., and Pickel, V.M. 2009. Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus. Neuroscience, 163, 129–142.
- De Bree, F.M., and Burbach, J.P. 1998. Structure-function relationships of the vasopressin prohormone domains. Cellular and Molecular Neurobiology, 18, 173–191.
- Enhorning, S., et al., 2010. Plasma copeptin and the risk of diabetes mellitus. Circulation, 121, 2102–2108.
- Grobe, J.L., Xu, D., and Sigmund, C.D. 2008. An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology (Bethesda), 23, 187–193.
- Head, G.A., and Mayorov, D.N. 2001. Central angiotensin and baroreceptor control of circulation. Annals of the New York Academy of Science, 940, 361–379.
- Itaya, Y., et al., 1986. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. American Journal of Physiology, 251, H261–H268.
- Katan, M., et al. 2009. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Annals of neurology, 66, 799–808.
- Katan, M., et al., 2008. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinology Letters, 29, 341–346.
- Krum, H., et al., 2009. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet, 373, 1275–1281.
- Littlejohn, N.K., et al., 2013. Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent. American Journal of Physiology Regulatory Integrative Comparative Physiology, 304, R818–R828.
- Mahfoud, F., et al., 2015. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. European Heart Journal, 36, 2219–2227.
- Mahfoud, F., et al., 2013. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. European Heart Journal, 34, 2149–2157.
- Morgenthaler, N.G., Struck, J., Alonso, C., and Bergmann, A. 2006. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clinical Chemistry, 52, 112–119.
- Reichlin, T., et al., 2009. Incremental value of copeptin for rapid rule out of acute myocardial infarction. Journal of American College of Cardiology, 54, 60–68.
- Schoen, T., et al., 2015. Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults. Journal of Hypertension, 33, 1571–1579.
- Slagman, A., Searle, J., Muller, C., and Mockel, M. 2015. Temporal release pattern of copeptin and troponin T in patients with suspected acute coronary syndrome and spontaneous acute myocardial infarction. Clinical Chemistry, 61, 1273–1282.
- Stewart, L.Q., et al., 2008. Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice. Journal of Neuroendocrinology, 20, 597–605.
- Tenderenda-Banasiuk, E., et al., 2014. Serum copeptin levels in adolescents with primary hypertension. Pediatric Nephrology, 29, 423–429.
- Uzun, F., et al., 2015. Serum copeptin levels in predicting nondippers in newly diagnosed hypertension. Blood Pressure Monitor, 20, 199–203.
- Voors, A.A., et al., 2009. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. European Heart Journal, 30, 1187–1194.